| P2093 | author name string | Polina Stepensky | |
| | Batia Avni | |
| | Sigal Grisariu | |
| | Reuven Or | |
| | Igor B Resnick | |
| | Michael Y Shapira | |
| P2860 | cites work | Primary refractory acute myeloid leukaemia - in search of better definitions and therapies | Q33877213 |
| | Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. | Q34049208 |
| | Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia | Q34380060 |
| | National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 |
| | Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation | Q34565838 |
| | Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. | Q34577019 |
| | Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research | Q35031141 |
| | Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy | Q42826040 |
| | NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia | Q43610177 |
| | Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors | Q44193839 |
| | Allogeneic peripheral blood stem cell transplantation is a promising and safe choice for the treatment of refractory/relapsed acute myelogenous leukemia, even with a higher leukemia burden | Q44957017 |
| | Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. | Q45245159 |
| | Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up | Q46782202 |
| | Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome. | Q52870483 |
| | Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). | Q54023930 |
| | Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). | Q54509279 |
| | Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study | Q58789014 |
| | Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F | Q66829418 |
| | Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome | Q73719654 |
| | Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors | Q73756651 |
| | Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia | Q82636889 |
| P433 | issue | 4 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 797-803 | |
| P577 | publication date | 2016-06-24 | |
| P1433 | published in | Hematological Oncology | Q15762617 |
| P1476 | title | Active acute leukaemia: should transplant be offered to all patients? | |
| P478 | volume | 35 | |